"In-licensing of new compounds in March does not indicate ACL's confidence of a strong trial result."I find it interesting they can base there recommendation around this premise
At the end of the day someone is going to be right and someone wrong in their prediction of trial results. I just hope for the sake of us retail shareholders the results are on the right side of the 'line'
"In-licensing of new compounds in March does not indicate ACL's...
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TSN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable